To hear about similar clinical trials, please enter your email below
Trial Title:
Italian Lung Cancer Observational Study
NCT ID:
NCT05851755
Condition:
Lung Cancer
Conditions: Official terms:
Lung Neoplasms
Study type:
Observational
Overall status:
Enrolling by invitation
Study design:
Time perspective:
Prospective
Summary:
LUCENT is an observational study focused on malignant pulmonary and tracheo-bronchial
disease. It involves a large proportion of reference Italian thoracic surgery centers.
The relevance of the study is related to the epidemiology of lung cancer in the world -
also known as "Big Killer" - and the high mortality rates both in males and females.
The aim of his prospective study is to collect a large bulk of postoperative patients'
outcome data and to produce up-to-date descriptive statistics of patients undergoing
surgery for lung cancer. These results will be pivotal to compare the clinical results of
all the relevant specialities involved in the care of lung cancer such as medical
oncologists and radiation oncologists.
Criteria for eligibility:
Study pop:
PaTientsin with lung cancer and an indication for respective surgery
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- Patients with lung cancer
- informed consent
Exclusion Criteria:
- alcohol or drug abuse
- age < 18
- inability to express consent
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
University of L'Aquila
Address:
City:
L'Aquila
Zip:
67100
Country:
Italy
Start date:
April 1, 2023
Completion date:
March 31, 2028
Lead sponsor:
Agency:
The Mediterranean Institute for Transplantation and Advanced Specialized Therapies
Agency class:
Other
Collaborator:
Agency:
S. Andrea Hospital
Agency class:
Other
Collaborator:
Agency:
Azienda Policlinico Umberto I
Agency class:
Other
Collaborator:
Agency:
Azienda Ospedaliero, Universitaria Pisana
Agency class:
Other
Collaborator:
Agency:
Università degli Studi dell'Aquila
Agency class:
Other
Collaborator:
Agency:
University of Milan
Agency class:
Other
Collaborator:
Agency:
Azienda Ospedaliera di Perugia
Agency class:
Other
Collaborator:
Agency:
Monaldi Hospital
Agency class:
Other
Collaborator:
Agency:
Azienda Ospedaliera di Bolzano
Agency class:
Other
Collaborator:
Agency:
AUSL Romagna Rimini
Agency class:
Other
Collaborator:
Agency:
European Institute of Oncology
Agency class:
Other
Collaborator:
Agency:
Università degli Studi di Ferrara
Agency class:
Other
Collaborator:
Agency:
Azienda Socio Sanitaria Territoriale di Mantova
Agency class:
Other
Source:
The Mediterranean Institute for Transplantation and Advanced Specialized Therapies
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05851755
